Search

Your search keyword '"Duke, Elizabeth"' showing total 115 results

Search Constraints

Start Over You searched for: Author "Duke, Elizabeth" Remove constraint Author: "Duke, Elizabeth" Database Unpaywall Remove constraint Database: Unpaywall
115 results on '"Duke, Elizabeth"'

Search Results

1. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study

4. Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium

7. Risk of COVID-19 after natural infection or vaccination

9. Cytomegalovirus

12. Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

13. Cancer Prevalence Across Vertebrates

14. Is chimerism associated with cancer across the tree of life?

15. FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors

16. BK Viremia and Changes in Estimated Glomerular Filtration Rate in Children and Young Adults after Hematopoietic Cell Transplantation

17. Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation

18. Cancer Prevalence Across Vertebrates

19. Life history and cancer in birds: clutch size predicts cancer

20. Is chimerism associated with cancer across the tree of life?

22. 631. CMV Reactivation in Hematopoietic Cell Transplant Candidates: A Novel Risk Factor for Post-transplant Reactivation

25. FDA Approval Summary: Mobocertinib for Metastatic Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

28. Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19

30. FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer

34. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

35. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates

38. CMV and HSV Pneumonia After Immunosuppressive Agents for Treatment of Cytokine Release Syndrome Due to Chimeric Antigen Receptor–modified T (CAR-T)-Cell Immunotherapy

39. Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal Infection

40. Molnupiravir, an Oral Antiviral Treatment for COVID-19

42. Infectious SARS-CoV-2 Virus in Symptomatic COVID-19 Outpatients: Host, Disease, and Viral Correlates

43. REMBI: Recommended Metadata for Biological Images—enabling reuse of microscopy data in biology

44. Cytomegalovirus-specific T-cell reconstitution following letermovir prophylaxis after hematopoietic cell transplantation

46. CMV viral load kinetics as surrogate endpoints after allogeneic transplantation

47. Developing a New Set of ACGME Milestones for Child Neurology Residency

Catalog

Books, media, physical & digital resources